Novus Pathologies Private Limited
About Novus Pathologies Private Limited
Data last updated:
Novus Pathologies Private Limited is a private limited company based in Dehradun, Uttarakhand, India. It operates in the diversified business activities segment of the business services sector. It was incorporated on 06 December 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Uttarakhand, under CIN U74999UR2016PTC007438.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Manoj Kumar Mishra and Narendrakumar Chandulal Bhatt.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at C/O Ruchi Mishra Dhoran Khas Maya Vihar Sahastradhara Road, Dehradun, Uttarakhand, India – 248001.
As per the financials filed for FY 2024, the company reported a revenue of ₹27,500, a decline of 8% compared to the previous year. For the same year it recorded a net profit of ₹3,075 (net margin 11.2%) and EBITDA of ₹19,000 (EBITDA margin 69.1%). Revenue has declined at a compounded annual rate (CAGR) of 19% over three years and 48% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressC/O Ruchi Mishra Dhoran Khas Maya Vihar Sahastradhara Road, Dehradun, Uttarakhand, India – 248001
- IndustryBusiness Services, Miscellaneous Business Activities, Other Services
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Novus Pathologies Private Limited
The main business activity of Novus Pathologies is support service to organizations. In detail, this covers other support services to organizations.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| N | Support service to Organizations | N7 | Other support services to organizations | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Novus Pathologies Private Limited FY 2025 filings available
Novus Pathologies Private Limited reported revenue of ₹27,500 (down 8% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Novus Pathologies Private Limited
Revenue has declined at a compounded annual rate (CAGR) of 48% over five years, including a 8% fall in the latest year. EBITDA fell 5% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Novus Pathologies Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹19,000 | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹3,075 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Novus Pathologies Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 69.1% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 11.2% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Novus Pathologies are in the company report.
Financial statements from FY 2017
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Novus Pathologies Private Limited
Novus Pathologies Private Limited is compared with the companies closest to it by revenue in the Healthcare industry (Diagnostics and Pathology Labs). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Cochin Diagnostics Research Centre Private Limited | ₹31,000 (FY 2024) | •••• | •••• | -60.0% | •••• | Ernakulam, Kerala, India |
| Meetansh Biotech Private Limited | ₹30,490 (FY 2019) | •••• | •••• | -91.0% | •••• | Ahmedabad, Gujarat, India |
| Alpha Global Health Partners Private Limited | ₹30,000 (FY 2025) | •••• | •••• | -38.0% | •••• | Delhi, India |
| Uniscan Diagnostic Private Limited | ₹28,544 (FY 2024) | •••• | •••• | 163.0% | •••• | Pune, Maharashtra, India |
| Sehat India Healthcare Services Private Limited | ₹27,939 (FY 2024) | •••• | •••• | •••• | Mumbai, Maharashtra, India | |
| Novus Pathologies Private Limited this company | ₹27,500 (FY 2024) | •••• | •••• | -8.0% | •••• | Dehradun, Uttarakhand, India |
| Panacea Medical Research and Diagnostic Centre Private Limited | ₹25,160 (FY 2024) | •••• | •••• | -59.0% | •••• | Guwahati, Assam, India |
| India Fertility Solutions Private Limited | ₹24,932 (FY 2024) | •••• | •••• | -92.0% | •••• | Delhi, India |
| Solaris Medicare Diagnostics Private Limited | ₹24,010 (FY 2025) | •••• | •••• | -57.0% | •••• | Auranagabad, Maharashtra, India |
| Wellogo Services Private Limited | ₹23,309 (FY 2024) | •••• | •••• | -99.0% | •••• | Delhi, India |
| Mediwin Diagnostic Centre Private Limited | ₹22,837 (FY 2025) | •••• | •••• | -100.0% | •••• | North 24 Parganas, West Bengal, India |
Peers are the five companies nearest above and the five nearest below Novus Pathologies by revenue in the Healthcare industry (Diagnostics and Pathology Labs), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Board of Directors of Novus Pathologies Private Limited
Novus Pathologies has 3 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Manoj Kumar Mishra Also directs: Vijric Technologies LLP | Director | 29 Mar 2024 | 2 Years 6 Months | Current |
| Narendrakumar Chandulal Bhatt Also directs: Medvita Healthtech Private Limited | Director | 28 Mar 2024 | 2 Years 6 Months | Current |
| Kashmira Narendra Bhatt | Director | 28 Mar 2024 | 2 Years 6 Months | Current |
Ownership and Shareholding of Novus Pathologies Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Novus Pathologies Private Limited
Novus Pathologies Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Novus Pathologies Private Limited
Employment history and EPFO contributions of people linked to Novus Pathologies.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Novus Pathologies Private Limited
Novus Pathologies Private Limited has 9 board changes on record since 2024: 3 appointments and 6 cessations. The latest: Vikas Kothiyal ceased to be Director on 07 Mar 2025.
Credit Ratings, Litigation & Regulatory Alerts for Novus Pathologies Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Novus Pathologies Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Novus Pathologies Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Novus Pathologies Private Limited
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Novus Pathologies Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Novus Pathologies Private Limited
Novus Pathologies is an active private limited company based in Dehradun, Uttarakhand, India. The company works in miscellaneous business activities, within the business services industry. It was incorporated on 06 December 2016 (10+ years old) and is registered under CIN U74999UR2016PTC007438.
Novus Pathologies reported revenue of ₹27,500 for FY 2024 (down 8% YoY).
Novus Pathologies has 3 current directors:
- Manoj Kumar Mishra - Director
- Narendrakumar Chandulal Bhatt - Director
- Kashmira Narendra Bhatt - Director
Novus Pathologies reported a net profit of ₹3,075 (net margin 11.2%) and EBITDA of ₹19,000 (EBITDA margin 69.1%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Novus Pathologies is -19% over three years and -48% over five years. In the latest year (FY 2024) revenue fell 8%. CAGR is the steady yearly rate that links the first and the last year.
The CIN (Corporate Identification Number) of Novus Pathologies is U74999UR2016PTC007438. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Novus Pathologies was incorporated on 06 December 2016, making it 10+ years old. It is registered with the Registrar of Companies, Uttarakhand.
The peers of Novus Pathologies by revenue are Cochin Diagnostics Research Centre Private Limited, Meetansh Biotech Private Limited, Alpha Global Health Partners Private Limited, Uniscan Diagnostic Private Limited, Sehat India Healthcare Services Private Limited and 5 more, all in the Healthcare industry (Diagnostics and Pathology Labs).
Vikas Kothiyal ceased to be Director on 07 Mar 2025. Kashmira Narendra Bhatt ceased to be Additional Director on 05 Apr 2024. Manoj Kumar Mishra ceased to be Additional Director on 05 Apr 2024. Novus Pathologies has 9 board changes on record in total.
The registered office of Novus Pathologies is at CO Ruchi Mishra Dhoran Khas Maya Vihar Sahastradhara Road, Dehradun, Uttarakhand, India – 248001.
Novus Pathologies has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh.